Medical practices choosing between custom and off-the-shelf software must weigh costs, flexibility, and efficiency—here’s how...
DEXI, an AI tool, assists dermatologists in evaluating skin lesions for cancer risk by analyzing...
Researchers at Mayo Clinic found measurable brain activity changes in 18 minutes of deep brain...
Mayo Clinic develops a real-time airborne pathogen detection system that could transform indoor biological threat...
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD,...
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...
FDA approval of Avulux migraine lenses offers an over‑the‑counter solution to reduce photophobia for migraine...
Australia cannot afford business as usual amid Northern Hemisphere fires, as global climate crises intensify....